Clinical trials

What are clinical trials?

Clinical trials are a vital part of improving treatment and care for people with myeloma. 

They test new drugs or treatments to find out what works best. Clinical trials also help researchers understand how people respond to different therapies, and how treatments can be delivered more safely and effectively. 

We’re building on what we’ve learned from more than a decade of supporting clinical trials – and shifting our efforts to where they can have the greatest impact.

Myeloma UK’s approach to clinical trials 

Our focus is on innovative trials that are shaped by the experiences and priorities of people living with myeloma. We’re investing in: 

• Smarter trial design 

• Patient-led research questions 

• Partnerships that improve access and speed up progress 

This approach puts real-world outcomes and equity at the centre of clinical research, so more people benefit, sooner. 

Our clinical trials work is part of a wider strategy to: 

• Find better treatment options for people whose myeloma is hard to treat 

• Reduce side effects and improve quality of life 

• Support personalised care through better trial design and access 

What we fund 

We fund the MyeTRIAL Partnership, which: 

• Supports the development of strategic trials, co-designed with people affected by myeloma 

• Tackles clinical and demographic barriers to clinical trial participation 

• Develops and promotes best practise in myeloma clinical trial design  

This work is supported by our wider investment in applied health research, which helps identify the challenges faced by people affected by myeloma and improve how studies are delivered.